Details of the Drug

General Information of Drug (ID: DMM10MW)

Drug Name

CUE-101

Indication

Disease Entry	ICD 11	Status	REF
Oropharyngeal squamous cell carcinoma	2B6A.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant?protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04852328) Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma. U.S. National Institutes of Health.